Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kannivelu Jagannath"'
Autor:
Mohideen S Jawahar, Vaithilingam V Banurekha, Chinnampedu N Paramasivan, Fathima Rahman, Rajeswari Ramachandran, Perumal Venkatesan, Rani Balasubramanian, Nagamiah Selvakumar, Chinnaiyan Ponnuraja, Allaudeen S Iliayas, Navaneethapandian P Gangadevi, Balambal Raman, Dhanaraj Baskaran, Santhanakrishnan R Kumar, Marimuthu M Kumar, Victor Mohan, Sudha Ganapathy, Vanaja Kumar, Geetha Shanmugam, Niruparani Charles, Murugesan R Sakthivel, Kannivelu Jagannath, Chockalingam Chandrasekar, Ramavaram T Parthasarathy, Paranji R Narayanan
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e67030 (2013)
Shortening tuberculosis (TB) treatment duration is a research priority. This paper presents data from a prematurely terminated randomized clinical trial, of 4-month moxifloxacin or gatifloxacin regimens, in South India.Newly diagnosed, sputum-positiv
Externí odkaz:
https://doaj.org/article/4f627962931f4e438dcaffc0b3d5bbdd
Autor:
P R Narayanan, Santhanakrishnan Ramesh Kumar, Dhanaraj Baskaran, Balambal Raman, R Balasubramanian, Murugesan Raja Sakthivel, Niruparani Charles, Vaithilingam V. Banurekha, Kannivelu Jagannath, Rajeswari Ramachandran, Allaudeen S. Iliayas, Chockalingam Chandrasekar, Perumal Venkatesan, Victor Mohan, Navaneethapandian P. Gangadevi, Ramavaram T. Parthasarathy, Sudha Ganapathy, M. S. Jawahar, Marimuthu Makesh Kumar, Fathima Rahman, Vanaja Kumar, Chinnampedu N. Paramasivan, Geetha Shanmugam, Nagamiah Selvakumar, C Ponnuraja
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 7, p e67030 (2013)
PLoS ONE, Vol 8, Iss 7, p e67030 (2013)
Background Shortening tuberculosis (TB) treatment duration is a research priority. This paper presents data from a prematurely terminated randomized clinical trial, of 4-month moxifloxacin or gatifloxacin regimens, in South India. Methods Newly diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a12bbe34fac4167f12ff667a1d3ef41
https://pubmed.ncbi.nlm.nih.gov/23843980
https://pubmed.ncbi.nlm.nih.gov/23843980
Autor:
Hildegard Boss, Pramod Niphadkar, Kannivelu Jagannath, S. Hellbardt, Nilkanth Awad, Durga A. Gadgil, Jyotsna M. Joshi
Publikováno v:
Clinical therapeutics. 27(11)
Objective: The efficacy of ciclesonide 160 μg QD (given either in the morning or evening) was compared with budesonide 200 μg BID in adults with stable asthma that was pretreated with inhaled corticosteroids. Methods: This was a randomized, 3-arm,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::868632cbe8eded309d5caddb3a0adda4
https://pubmed.ncbi.nlm.nih.gov/16368446
https://pubmed.ncbi.nlm.nih.gov/16368446